Continuous long-term dosing with oral slow-release isosorbide dinitrate does not reduce incidence of cardiac events in patients with healed myocardial infarction

Clinical Cardiology

Volumn 24, Issue 9, 2001, Pages 608-614

  Kanamasa, K ^a   Hayashi, T ^a   Takenaka, T ^a   Kimura, A ^a   Ikeda, A ^a   Ishikawa, K ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac events; Isosorbide dinitrate; Myocardial infarction; Nitrate tolerance

Indexed keywords

ISOSORBIDE DINITRATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SLOW RELEASE FORMULATION; STATISTICAL ANALYSIS; SUDDEN DEATH;

EID: 0034865710     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960240908     Document Type: Article

References (38)

1. ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations
2. Oral anti-anginal nitrates should be indicated only for single, not chronic, use in absence of long-term data, FDC Cardio-Renal Drugs Advisory CMTE concludes
3. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction
4. Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale post-infarction studies
5. New insights into mechanisms underlying nitrate tolerance
6. Phenomenon of nitrate tolerance
7. Tolerance, rebound, and time-zero effect of nitrate therapy
8. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia
9. Correlative classification of clinical and hemodynamic function after acute myocardial infarction
10. Treatment of myocardial infarction in a coronary care unit. A two years experience with 250 patients
11. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction
12. Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement
13. Angina pectoris I. A variant form of angina pectoris. Preliminary report
14. Cardiac arrest and sudden cardiac death
15. Estimability and estimation in case-referent studies
16. Role of nitrates after acute myocardial infarction
17. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials
18. Influence of long-acting nitrate therapy on the risk of reinfarction, sudden death, and total mortality in survivors of acute myocardial infarction
19. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
20. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
21. Optimal management of acute myocardial infarction at the dawn of the next millennium
22. Transdermal nitroglycerine patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction. Results of a multicenter prospective randomized, double-blind, placebo-controlled trial
23. The effects of oral isosorbide 5-mononitrate on mortality following acute myocardial infarction: A multicentre study
24. Effects of continuous intravenous infusion of isosorbide dinitrate on development of tolerance to vasodilating action in human epicardial coronary arteries
25. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin
26. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine
27. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure
28. Coronary artery spasm after abrupt withdrawal of nitroglycerin in rabbits
29. Unusual vasomotor coronary arterial responses after nitroglycerin
30. Paradoxical angina after nitroglycerin - Another variant
31. Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta
32. 1 adrenoreceptors by nitroglycerin
33. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance
34. Antiplatelet and antithrombotic effects of organic nitrates
35. Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm
36. Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina
37. Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine
38. Long-term nitrate use in chronic coronary artery disease: Need for a randomized controlled trial